Signal active
Bio
Roger M. Perlmutter, M.D., Ph.D., joined Merck in 2013 as the executive vice president and president of Merck Research Laboratories.
He was formerly executive vice president and head of R&D at Amgen from January 2001 to February 2012. During his tenure, he oversaw the development and subsequent approval of a number of novel biologic and small molecule medicines in the areas of cancer, endocrinology, hematology, inflammation and osteoporosis.
Prior to joining Amgen, Dr. Perlmutter held roles of increasing responsibility at Merck Research Laboratories, culminating in his appointment to executive vice president of Worldwide Basic Research and Preclinical Development. He joined Merck as a senior vice president in February 1997.
Most recently, he served as a director of several biotechnology companies and was a science partner at The Column Group, a biotechnology-focused venture capital firm.
Before assuming leadership roles in industry, Dr. Perlmutter was a professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington and also served as chairman of its Department of Immunology where he was a Howard Hughes Medical Institute investigator. His research focused on understanding the signaling pathways that control lymphocyte activation.
Prior to this, he was a lecturer in the Division of Biology at the California Institute of Technology.
Dr. Perlmutter graduated from Reed College in Portland, Ore., and received his M.D. and Ph.D. degrees from Washington University in St. Louis, Mo. He completed his clinical training in internal medicine at the Massachusetts General Hospital and at the University of California at San Francisco.
Dr. Perlmutter is a Fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science.
Location
N/A
Social
N/A
Primary Organization
1891
24
6
10
10001+
Biotechnology, Health Care, Pharmaceutical, Medical
Jobs history
1
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Roger Perlmutter is the EVP & President, Merck Research Laboratories at Merck. With a background in Biotechnology, Roger Perlmutter has a rich history of leadership and innovation. Roger Perlmutter studied unknown unknown @ Washington University in St. Louis. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.